Skip to main content

Product Watch: Jun 16, 2011


Biogazelle is now offering qBase Plus 2, the next generation of the company's quantitative real-time PCR data-analysis software.

Based on peer-reviewed geNorm and qBase technology from Ghent University, qBase Plus 2 is enhanced with proprietary algorithms and time-saving features, Biogazelle said. Extra features include sample grouping ability; new core modules for copy number variant analysis and other applications; and alternative normalization methods, such as global mean normalization.

Available for Windows, Mac, and Linux, qBase Plus 2 uses a completely rewritten calculation engine, making it ideal for high-throughput real-time PCR data analysis on standard computers, Biogazelle said. The software also comes with an integrated statistical analysis wizard that eliminates the need for in-depth knowledge about biostatistics.

Biogazelle is offering two types of licenses: premium, which comes with all analysis features including 12 months of priority support and software upgrade protection; and basic, which comes with the most important data-analysis features but has restrictions on high-throughput data processing, the company said.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.